Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics Statistics

Total Valuation

RAPP has a market cap or net worth of $1.33 billion. The enterprise value is $851.50 million.

Market Cap	1.33B
Enterprise Value	851.50M

Important Dates

The last earnings date was Tuesday, March 10, 2026, before market open.

Earnings Date	Mar 10, 2026
Ex-Dividend Date	n/a

Share Statistics

RAPP has 47.79 million shares outstanding. The number of shares has increased by 87.74% in one year.

Current Share Class	47.80M
Shares Outstanding	47.79M
Shares Change (YoY)	+87.74%
Shares Change (QoQ)	+23.85%
Owned by Insiders (%)	4.57%
Owned by Institutions (%)	76.28%
Float	30.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.74
P/TBV Ratio	2.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 26.17, with a Debt / Equity ratio of 0.02.

Current Ratio	26.17
Quick Ratio	25.75
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.22% and return on invested capital (ROIC) is -19.47%.

Return on Equity (ROE)	-28.22%
Return on Assets (ROA)	-18.90%
Return on Invested Capital (ROIC)	-19.47%
Return on Capital Employed (ROCE)	-25.36%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.33M
Employee Count	84
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +178.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+178.12%
50-Day Moving Average	28.18
200-Day Moving Average	22.76
Relative Strength Index (RSI)	44.82
Average Volume (20 Days)	368,086

Short Selling Information

The latest short interest is 3.51 million, so 7.35% of the outstanding shares have been sold short.

Short Interest	3.51M
Short Previous Month	3.40M
Short % of Shares Out	7.35%
Short % of Float	11.42%
Short Ratio (days to cover)	11.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-125.10M
Pretax Income	-111.48M
Net Income	-111.48M
EBITDA	-124.08M
EBIT	-125.10M
Earnings Per Share (EPS)	-$2.86

Balance Sheet

The company has $490.54 million in cash and $11.48 million in debt, with a net cash position of $479.06 million or $10.02 per share.

Cash & Cash Equivalents	490.54M
Total Debt	11.48M
Net Cash	479.06M
Net Cash Per Share	$10.02
Equity (Book Value)	484.65M
Book Value Per Share	10.15
Working Capital	479.51M

Cash Flow

In the last 12 months, operating cash flow was -$87.47 million and capital expenditures -$616,000, giving a free cash flow of -$88.09 million.

Operating Cash Flow	-87.47M
Capital Expenditures	-616,000
Free Cash Flow	-88.09M
FCF Per Share	-$1.84

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-87.74%
Shareholder Yield	-87.74%
Earnings Yield	-8.38%
FCF Yield	-6.62%

Analyst Forecast

The average price target for RAPP is $48.50, which is 74.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$48.50
Price Target Difference	74.21%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-0.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1